| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
11,136,520 | 11,952,063 | 14,538,987 | 13,568,371 | 12,949,902 |
| Cost of Revenue
|
-8,558,946 | -8,986,940 | -11,279,954 | -10,859,718 | -11,667,224 |
|
Gross Profit
|
2,577,574 | 2,965,123 | 3,259,033 | 2,708,653 | 1,282,678 |
| Selling, General and Administrative Expenses
|
-871,924 | -927,463 | -959,133 | -796,336 | -1,039,411 |
|
Research and Development Expenses
|
-2,204,686 | -2,170,331 | -2,133,128 | -1,789,672 | -2,536,509 |
|
Operating Income/Expenses
|
-3,076,610 | -3,097,794 | -3,092,261 | -2,586,008 | -3,575,920 |
|
Total Operating Profit/Loss
|
-499,036 | -132,671 | 166,772 | 122,645 | -2,293,242 |
| Total Net Finance Income/Expense
|
195,193 | 222,402 | 317,937 | 211,924 | 42,504 |
| Net Investment Income
|
101,217 | 31,037 | 27,936 | 38,344 | 182,446 |
| Irregular Income/Expenses
|
-1,237,268 | -1,237,268 | 0 | -- | -- |
|
Other Income/Expense, Non-Operating
|
265,302 | 98,359 | 68,086 | 52,804 | 207,675 |
|
Non-Operating Income/Expenses, Total
|
-675,556 | -885,470 | 413,959 | 303,072 | 432,625 |
|
Pretax Income
|
-1,174,592 | -1,018,141 | 580,731 | 425,717 | -1,860,617 |
| Provision for Income Tax
|
72,595 | 27,883 | -12,275 | -72,702 | -68,278 |
|
Net Income from Continuing Operations
|
-1,101,997 | -990,258 | 568,456 | 353,015 | -1,928,895 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-1,101,997 | -990,258 | 568,456 | 353,015 | -1,928,895 |
|
Non-Controlling/Minority Interests
|
-263 | -343 | 5,606 | 8,904 | 16,856 |
|
Net Income after Non-Controlling/Minority Interests
|
-1,102,260 | -990,601 | 574,062 | 361,919 | -1,912,039 |
|
Net Income Available to Common Stockholders
|
-1,102,260 | -990,601 | 574,062 | 361,919 | -1,912,039 |
|
Diluted Net Income Available to Common Stockholders
|
-1,102,260 | -990,601 | 574,062 | 361,919 | -1,912,039 |
| Basic EPS
|
-5.16 | -4.64 | 2.71 | 1.74 | -9.39 |
| Diluted EPS
|
-5.16 | -4.64 | 2.64 | 1.69 | -9.39 |
|
Basic Weighted Average Shares Outstanding
|
213,125.11 | 213,491.60 | 211,831 | 207,999.43 | 203,625.03 |
|
Diluted Weighted Average Shares Outstanding
|
213,886.65 | 213,491.60 | 217,447.73 | 214,153.25 | 213,805.48 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-1,369,785 | -1,240,543 | 262,794 | 213,793 | -1,903,121 |
|
EBITDA
|
-881,671 | -820,923 | 518,300 | 419,293 | -1,711,461 |
|
Normalized EBITDA
|
102,137 | 287,571 | 204,457 | -737,757 | 798,842 |
|
Normalized Income
|
-178,992.27 | 87,878.78 | 261,246.70 | -606,439.79 | 79,347.40 |
|
Total Unusual Items
|
983,808 | 1,108,494 | -313,843 | -1,157,050 | 2,510,303 |
12/31/2022 - 7/3/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade